Octapharma France company information, Employees & Contact Information

Octapharma Releases Results for Phase 3 Superiority Study of Pediatric Acute-onset Neuropsychiatric Syndrome PR Newswire

$2.55M Octapharma Plasma data breach class action settlement Class Action Lawsuits

Octapharma USA: JAMA Publishes Results for Investigational Four-Factor Prothrombin Complex Concentrate in Cardiac Surgical Bleeding PR Newswire

A Major Clinical Trial Could Revolutionize Trauma Care for Life-Threatening Bleeding CU Anschutz newsroom

Newly opened Kentwood plasma donation center helping save lives while providing income for donors FOX 17 West Michigan News

Plasma donation center in Kentwood celebrates opening woodtv.com

Octapharma secures FDA nod for warfarin reversal agent Balfaxar Fierce Pharma

Octapharma Plasma opens fourth Central California location ABC30 Fresno

News | New Pay-for-Blood Plasma Business Coming to Providence - Elected Official Warns of “Exploitation” GoLocalProv

FDA Approves Expanded Indication for Octapharma’s Fibryga for Patients Experiencing Bleeding Due to Acquired Fibrinogen Deficiency Pharmaceutical Executive

Octapharma Plasma expanding U.S. HQ with $18.75M building acquisition The Business Journals

Octapharma USA to present clinical overview of dermatomyositis during The Myositis Association’s Annual Conference EurekAlert!

Octapharma Plasma Launches Pilot To Get Paid In Bitcoin For Plasma Donations Bitcoin Magazine

Octapharma USA Receives FDA Emergency Use Authorization for octaplasLG Powder, Allows U.S. Military Medical Providers Emergent Use in Treatment of Hemorrhage or Coagulopathy PR Newswire

Octapharma Announces Availability of Balfaxar® For Warfarin Reversal in Urgent Surgery & Invasive Procedures PR Newswire

Octapharma USA: FDA Grants Expanded Approval to wilate® as the First VWF Concentrate for Prophylaxis in All Types of VWD PR Newswire

Octapharma USA: FDA Grants Orphan Drug Exclusivity to wilate®, the First VWF Concentrate for Prophylaxis in All Types of VWD PR Newswire

FDA Approves Additional Indication for Fibryga® for Fibrinogen Supplementation in Bleeding Patients with Acquired Fibrinogen Deficiency, Potentially Ushering in a New Standard of Care PR Newswire

Octapharma USA Requests FDA Approval for wilate® VWD Prophylaxis Supplement PR Newswire

Octapharma's Prothrombin Complex Concentrate, Balfaxar®, Receives FDA Approval For Warfarin Reversal in Urgent Surgery & Invasive Procedures PR Newswire

FDA approves Octapharma's Octagam® 10% for adult dermatomyositis EurekAlert!

Octapharma Uses IVIG as Potential Treatment for COVID-19 BioSpace

FDA Approves Octapharma’s cutaquig® 16.5% for Pediatric PI Patients, Providing Flexible Treatment Options BioSpace

Exclusive: BlackSuit ransomware gang claims hack on Octapharma Plasma Cyber Daily

As Omicron Spreads Nationally, Octapharma’s fibryga® & Octaplas™ Become Increasingly Important Replacement Therapies BioSpace

Octapharma USA Sponsors Educational National Conference for Type 3 Von Willebrand Disease Patients PR Newswire

Blood money: Octapharma facility, offering cash for plasma, pops up in Brockton Enterprise News

FDA Clears Freeze-Dried Plasma Transfusion Powder for Military Emergency Use The Defense Post

10% Receives 7 Years of Market Exclusivity for Adult Dermatomyositis Business Wire

Octapharma Group Reports Strong Results for 2018 BioSpace

FDA Extends Shelf Life of Octapharma’s cutaquig® 16.5% for Adult PI Patients Business Wire

Octapharma ordered to pay $105K after terminating worker who needed accommodation to care for cancer-stricken mom HR Law Canada

joliark restores abandoned stockholm brewery for octapharma Designboom

Octapharma goes for Schreiner MediPharm automatic dispensing system Emballage Digest

Octapharma Brewery Domus Web

Octapharma Plasma Pay Chart (Up to $1,000 for New Donors in 2025) MoneyPantry.com